Assignee
BIOATLA LLC
US·22 granted patents·8 pending applications·49 citations·filing 2013–2020
Top patents by PatentIndex Score
30 records- 0195US11111288B2Conditionally active chimeric antigen receptors for modified t-cellsBIOATLA LLC·Filed 2018·Granted Sep 7, 2021·9 cites·23 claims
- 0291US11279924B2Conditionally active polypeptides and methods of generating themBIOATLA LLC·Filed 2017·Granted Mar 22, 2022·3 cites·21 claims
- 0391US11254932B2Conditionally active biological proteinsBIOATLA LLC·Filed 2020·Granted Feb 22, 2022·2 cites·32 claims
- 0490US10513699B2Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hostsBIOATLA LLC·Filed 2015·Granted Dec 24, 2019·5 cites·25 claims
- 0589US11149088B2Anti-Axl antibodies, antibody fragments and their immunoconjugates and uses thereofBIOATLA LLC·Filed 2017·Granted Oct 19, 2021·3 cites·6 claims
- 0687US9856323B2Anti-CD22 antibodiesBIOATLA LLC·Filed 2013·Granted Jan 2, 2018·10 cites·22 claims
- 0786US9637734B2Mirac proteinsBIOATLA LLC·Filed 2014·Granted May 2, 2017·5 cites·30 claims
- 0884US10047357B2Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hostsBIOATLA LLC·Filed 2014·Granted Aug 14, 2018·2 cites·14 claims
- 0983US11254742B2Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereofBIOATLA LLC·Filed 2017·Granted Feb 22, 2022·1 cites·34 claims
- 1081US10696750B2Multi-specific monoclonal antibodiesBIOATLA LLC·Filed 2019·Granted Jun 30, 2020·1 cites·20 claims
- 1180US9637735B2Mirac proteinsBIOATLA LLC·Filed 2014·Granted May 2, 2017·2 cites·31 claims
- 1279US10329556B2Conditionally active biological proteinsBIOATLA LLC·Filed 2015·Granted Jun 25, 2019·2 cites·13 claims
- 1378US9994841B2Mirac proteinsBIOATLA LLC·Filed 2016·Granted Jun 12, 2018·1 cites·32 claims
- 1476US10563194B2Conditionally active biological proteinsBIOATLA LLC·Filed 2016·Granted Feb 18, 2020·1 cites·17 claims
- 1576US9982252B2Mirac proteinsBIOATLA LLC·Filed 2014·Granted May 29, 2018·1 cites·16 claims
- 1673US10920216B2Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hostsBIOATLA LLC·Filed 2018·Granted Feb 16, 2021·0 cites·20 claims
- 1772US9969813B2Multi-specific monoclonal antibodiesBIOATLA LLC·Filed 2013·Granted May 15, 2018·1 cites·15 claims
- 1868US10829513B2Methods of protein evolutionBIOATLA LLC·Filed 2018·Granted Nov 10, 2020·0 cites·13 claims
- 1963US10954288B2Modified antibody regions and uses thereofBIOATLA LLC·Filed 2018·Granted Mar 23, 2021·0 cites·7 claims
- 2063US10562981B2Express humanization of antibodiesBIOATLA LLC·Filed 2017·Granted Feb 18, 2020·0 cites·20 claims
- 2162US2020216834A1Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hostsBIOATLA LLC·Filed 2019·Application pending·0 cites
- 2257US2019010219A1Conditionally Active Chimeric Antigen Receptors for Modified T-CellsBIOATLA LLC·Filed 2016·Application pending·0 cites
- 2357US2016207989A1Conditionally active chimeric antigen receptors for modified t-cellsBIOATLA LLC·Filed 2016·Application pending·0 cites
- 2456US11293929B2Proteins targeting orthologsBIOATLA LLC·Filed 2015·Granted Apr 5, 2022·0 cites·19 claims
- 2556US2018237543A1Multi-specific monoclonal antibodiesBIOATLA LLC·Filed 2018·Application pending·0 cites
- 2655US2017260261A1Conditionally Active Chimeric Antigen Receptors for Modified T-CellsBIOATLA LLC·Filed 2015·Application pending·0 cites
- 2754US2019284551A1Conditionally Active Biological ProteinsBIOATLA LLC·Filed 2019·Application pending·0 cites
- 2851US2015065690A1Modified antibody regions and uses thereofBIOATLA LLC·Filed 2013·Application pending·0 cites
- 2948US2018086843A1Anti-cd22 antibodiesBIOATLA LLC·Filed 2017·Application pending·0 cites
- 3044US10697972B2Diagnostics using conditionally active antibodiesBIOATLA LLC·Filed 2017·Granted Jun 30, 2020·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when BIOATLA LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →